The impact of Kaposi sarcoma and non-Hodgkin lymphoma on mortality of people with AIDS in the highly active antiretroviral therapies era

Diego Serraino, Angela De Paoli, Antonella Zucchetto, Simona Pennazza, Silvia Bruzzone, Michele Spina, Paolo De Paoli, Giovanni Rezza, Luigino Dal Maso, Barbara Suligoi

Research output: Contribution to journalArticle

Abstract

Background: Kaposi sarcoma (KS) and non-Hodgkin lymphoma (NHL) have strongly diminished in the HAART era, but their impact on life expectancy of people with AIDS (PWA) needs to be monitored. We aimed at quantifying the burden of KS and NHL on mortality of PWA in the HAART period in Italy. Methods: Death certificates of 3209 PWA diagnosed in 1999-2006 who died as of December 2006 were reviewed to identify those deaths in which KS or NHL was the underlying cause. Standardized mortality ratios (SMR) were computed. Results: KS or NHL appeared in 4.3% and 14.6% death certificates, respectively; they were the underlying cause of death in 3.1% and 13.4% of cases. SMR were 8698-fold higher for KS and 349-fold higher for NHL, and tended to decline over the study period. Conclusion: KS and NHL caused about 16% of deaths of PWA in the HAART era, with 100-fold higher risks of death compared to the Italian general population also in recent years. Clinicians and public health officials should be aware of the persisting negative impact of these cancers on life expectancy of PWA.

Original languageEnglish
Pages (from-to)257-261
Number of pages5
JournalCancer Epidemiology
Volume34
Issue number3
DOIs
Publication statusPublished - Jun 2010

Keywords

  • AIDS
  • Kaposi sarcoma
  • Mortality
  • Non-Hodgkin lymphoma

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Epidemiology

Fingerprint Dive into the research topics of 'The impact of Kaposi sarcoma and non-Hodgkin lymphoma on mortality of people with AIDS in the highly active antiretroviral therapies era'. Together they form a unique fingerprint.

Cite this